$64.46
-0.04[-0.06%]
At close: Apr 17
$64.46
0[0.00%]
After Hours: 4:00PM EDT
Alpine Immune Sciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Alpine Immune Sciences using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | PM | ALPN | Q1 | -$0.28 | -$0.42 | — | — | $9.39M | $4.22M | — | — | Get Alert |
03/18/2024 | PM | ALPN | Q4 | -$0.41 | -$0.34 | $0.15 | 144.12% | $2.78M | $9.10M | $30.85M | 239.04% | Get Alert |
11/14/2023 | PM | ALPN | Q3 | -$0.42 | -$0.33 | -$0.24 | 27.27% | $8.37M | $7.25M | $10.04M | 38.52% | Get Alert |
08/14/2023 | PM | ALPN | Q2 | -$0.60 | -$0.37 | -$0.27 | 27.03% | $5.29M | $8.85M | $8.59M | -2.90% | Get Alert |
05/11/2023 | PM | ALPN | Q1 | -$0.25 | -$0.37 | -$0.28 | 24.32% | $13.63M | $8.60M | $9.39M | 9.15% | Get Alert |
03/23/2023 | PM | ALPN | Q4 | -$0.52 | -$0.27 | -$0.41 | -51.85% | $4.53M | $10.96M | $2.78M | -74.67% | Get Alert |
11/14/2022 | PM | ALPN | Q3 | -$0.55 | -$0.10 | -$0.42 | -320.00% | $8.52M | $18.68M | $8.37M | -55.21% | Get Alert |
08/11/2022 | PM | ALPN | Q2 | -$0.46 | -$0.39 | -$0.60 | -53.85% | $7.19M | $10.04M | $5.29M | -47.29% | Get Alert |
05/12/2022 | PM | ALPN | Q1 | -$0.45 | -$0.19 | -$0.25 | -31.58% | $3.20M | — | $13.63M | — | Get Alert |
03/17/2022 | PM | ALPN | Q4 | -$0.27 | -$0.30 | -$0.52 | -73.33% | $5.64M | $13.97M | $4.53M | -67.57% | Get Alert |
11/10/2021 | PM | ALPN | Q3 | -$0.28 | $0.00 | -$0.55 | — | $1.91M | $21.19M | $8.52M | -59.81% | Get Alert |
08/10/2021 | PM | ALPN | Q2 | -$0.53 | -$0.40 | -$0.46 | -15.00% | $688.00K | $6.48M | $7.19M | 11.00% | Get Alert |
05/13/2021 | PM | ALPN | Q1 | -$0.30 | -$0.36 | -$0.45 | -25.00% | $1.09M | $5.56M | $3.20M | -42.37% | Get Alert |
03/18/2021 | PM | ALPN | Q4 | -$0.33 | -$0.31 | -$0.27 | 12.90% | $884.00K | $2.59M | $5.64M | 117.88% | Get Alert |
11/12/2020 | PM | ALPN | Q3 | -$0.62 | -$0.23 | -$0.28 | -21.74% | $289.00K | — | $1.91M | — | Get Alert |
08/11/2020 | PM | ALPN | Q2 | -$0.64 | — | -$0.53 | — | $567.00K | — | $688.00K | — | Get Alert |
05/14/2020 | PM | ALPN | Q1 | -$0.70 | — | -$0.30 | — | $0.00 | — | $1.09M | — | Get Alert |
03/30/2020 | PM | ALPN | Q4 | -$0.80 | -$0.58 | -$0.33 | 43.10% | $0.00 | $180.00K | $884.00K | 391.11% | Get Alert |
11/13/2019 | PM | ALPN | Q3 | -$0.88 | -$0.68 | -$0.62 | 8.82% | $0.00 | $190.00K | $289.00K | 52.11% | Get Alert |
Alpine Immune Sciences (ALPN) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on March 18, 2024 for Q4.
The Actual EPS was $0.15, which beat the estimate of $-0.34.
The Actual Revenue was $30.9M, which beat the estimate of $9.1M.
Browse earnings estimates, EPS, and revenue on all stocks.